TABLE 1.
Clinical characteristics
| Parameter | Median value (IQR) or no. of individuals from each cohorte |
|
|---|---|---|
| Recent infection (n = 81) | Chronic (n = 406) | |
| Plasma viral load (log10 HIV RNA copies/ml) | 5.0 (4.2–5.3) | 4.8b (4.2–5.3) |
| Baseline CD4+ T cell count (cells/mm3) | 419 (230–482) | 338c (230–479) |
| Baseline age (yr) | 26 (23–30) | 31d (26–36) |
| Gender, no. (%) | ||
| Female | 56 (69) | 320 (79) |
| Male | 25 (31) | 86 (21) |
| Estimated time postinfection (days) | 49a (34–69) | ND |
a
Days postinfection could be estimated for 76 individuals; the remaining 5 were identified in Fiebig stage VI.
b
Plasma viral load was available for 400 individuals.
c
Baseline CD4+ T cell count was available for 405 individuals.
d
Age was available for 402 individuals.
e
All values, except for those for gender, are indicated as median and IQR. ND, not determined.